>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle

Global Standardized Financials

11.72 -0.08 (-0.68%) 08/14/2026
Candel Therapeutics, Inc. (CADL)
Income Statement
(Values in Thousands)
 Q2 2026 (Jun 30, 2026)Q1 2026 (Mar 31, 2026)Q4 2025 (Dec 31, 2025)Q3 2025 (Sep 30, 2025)Q2 2025 (Jun 30, 2025)Q1 2025 (Mar 31, 2025)Q4 2024 (Dec 31, 2024)Q3 2024 (Sep 30, 2024)Q2 2024 (Jun 30, 2024)Q1 2024 (Mar 31, 2024)Q4 2023 (Dec 31, 2023)Q3 2023 (Sep 30, 2023)Q2 2023 (Jun 30, 2023)Q1 2023 (Mar 31, 2023)Q4 2022 (Dec 31, 2022)Q3 2022 (Sep 30, 2022)Q2 2022 (Jun 30, 2022)Q1 2022 (Mar 31, 2022)Q4 2021 (Dec 31, 2021)Q3 2021 (Sep 30, 2021)Q2 2021 (Jun 30, 2021)Q1 2021 (Mar 31, 2021)Q4 2020 (Dec 31, 2020)Q3 2020 (Sep 30, 2020)Q2 2020 (Jun 30, 2020)Q1 2020 (Mar 31, 2020)
Net Income-38,905-8,861-29,496-11,269-4,7967,379-14,073-10,646
Revenue
Cost Of Revenue2455,272
Gross Profit-245-5,272
Operating Expenses26,74616,28415,75213,20711,1778,1307,8963,485
Selling General and Administrative Expenses6,9456,4444,7244,7464,1864,1143,3243,485
Research and Development Expenses19,8019,84011,0288,4616,9914,0164,5725,416
Other Expenses-5,416
Cost And Expenses16,28415,75213,20711,1778,1308,1418,757
Operating Income-26,746-16,284-15,752-13,207-11,177-8,130-8,141-8,757
Interest Income1,6721,3221,102953926934290236
Income Tax Expense
Income Before Tax-38,905-8,861-29,496-11,269-4,7967,379-14,073-10,646
Earning Per Share Basic-0.52-0.14-0.54-0.21-0.090.23-0.40-0.33
Earning Per Share Diluted-0.52-0.14-0.54-0.21-0.090.23-0.40-0.33
weighted Average Shares Outstanding74,13162,36254,89854,89451,49031,67535,56532,014
weighted Average Shares Outstanding (Diluted)74,13162,36254,89854,89451,49031,67535,56532,014
Gross Margin
EBIT Margin
Profit Margin
EBITDA-26,746-7,148-27,917-10,913-4,3187,930-13,438-8,512
Earning Before Tax Margin

Market News ×
Loading news…